Products
Back
Products
Core Disciplines
Chemistry Immunoassay Hematology Urinalysis Microbiology Blood Banking Clinical Decision Support Protein Chemistry Service
Workflow & Informatics
Automation Systems DxA 5000 Total Lab Automation DxA 5000 Fit Automation System Advanced Informatics Remisol Advance Middleware Remote Services & Diagnostics
Solutions For
Pioneering Digital Hematology Neurology High Sensitivity Diagnostics Host Response to Infection Cardiovascular Disease IDBV Solutions Diabetes Diagnostics Drug Monitoring & Detection Sepsis
Support
Back
Support
Account Support
Create Account Manage Account Settings View All Account Support
Product Support
DxS Service In Vitro Diagnostic Regulation (IVDR) Manage My Technical Documents Search for Technical Documents Safety Data Sheets (SDS/MSDS) Search for Software Downloads Technical Documents Overview Manage My Regulatory Notifications Manage My Warranties & Agreements Request Instrument Support View Services Information View All Product Support Access Quality Assurance Programs
Ordering Support
Order Status & Tracking Track My Invoices View Return/RMA Policy Get Help with Orders View All Ordering Support
Resources
Back
Resources
Product Training
Browse Learning Lab › Learning Lab Login ›
Education & Research
Webinars Posters 3D Virtual Laboratory Showcase
Insights
Clinical Studies & Trends Case Studies Publications
Company
Back
Company
People & Culture
Overview Meet Our Teams Diversity + Inclusion How We Work Innovation
Careers
Job Search › Programs & Grants Office Locations
News & Events
Awards & Recognition Newsroom Blog Events Calendar
Home / Resources / Posters / Meropenem Vaborbactam MIC Results for Enterobacterales

ECCMID 2020 Scientific Poster: Meropenem/Vaborbactam MIC Results for Enterobacterales and Pseudomonas aeruginosa

 

Multicenter Evaluation of Meropenem/Vaborbactam MIC Results for Enterobacterales and Pseudomonas aeruginosa Using EUCAST Breakpoints on MicroScan Dried Gram Negative MIC Panels

A. Harrington1, S. DesJarlais1, O.B. Garner2, M. Traczewski3, D. Beasley3, C. J. Hastey4, R.K. Brookman4, Z.C. Lockett4, J.Y. Chau4, and B.L. Zimmer4
1Loyola University Medical Center, Maywood, IL, 2UCLA David Geffen School of Medicine, Los Angeles, CA, 3Clinical Microbiology Institute, Wilsonville, OR, and 4Beckman Coulter Microbiology, West Sacramento, CA


Background

A multicenter study was performed to evaluate the accuracy of testing meropenem/vaborbactam on a MicroScan Dried Gram-negative MIC (MSDGN) Panel when compared to a frozen ISO/CLSI broth microdilution reference panel.

Materials/Methods

An evaluation was conducted at three U.S. sites by comparing MIC values obtained using the MSDGN to MICs utilizing an ISO/CLSI broth microdilution reference panel. A total of 775 Enterobacterales and P. aeruginosa clinical isolates were tested using the turbidity and Prompt® methods of inoculation during the efficacy phase. A subset of 14 organisms for reproducibility was tested on MSDGN panels at each site. MSDGN panels were incubated at 35 ± 1ºC and read on the WalkAway System, the autoSCAN-4 instrument, and read visually. Read times for the MSDGN panels were at 16-20 hours. Frozen reference panels were prepared according to ISO/CLSI methodology, incubated for 16-20 hours and read visually. EUCAST breakpoints (mg/L) used for interpretation of MIC results were: Enterobacterales ≤ 8/8 S, > 8/8 R and P. aeruginosa ≤ 8/8 S, > 8/8 R.

Results

Essential and categorical agreement when compared to frozen reference panel results, for all isolates tested in efficacy as follows:

 

Read Method

Essential Agreement %

Categorical Agreement %

Very Major Error (VMJ)* %

Major Error (MAJ)* %

P T P T P T P T
WalkAway 99.2 (769/775) 99.2 (769/775) 99.5 (771/775) 99.5 (771/775) 0.0 (0/6) 0.0 (0/6) 0.1 (1/769) 0.3 (2/769)
autoSCAN-4 99.2 (769/775) 99.1 (768/775) 99.7 (773/775) 99.5 (771/775) 0.0 (0/6) 0.0 (0/6) 0.1 (1/769) 0.3 (2/769)
Visually 99.5 (771/775) 99.1 (768/775) 99.9 (774/775) 99.6 (772/775) 0.0 (0/6) 0.0 (0/6) 0.1 (1/769) 0.3 (2/769)

T = Turbidity inoculation method, P = Prompt inoculation method

*Calculation of MAJ and VMJ excluding 1 well errors

Conclusion

This multicenter study showed that meropenem/vaborbactam MIC results for Enterobacterales and P. aeruginosa obtained with the MSDGN panel correlate well with MICs obtained using frozen reference panels using EUCAST interpretive criteria.
MIC panel scientific poster

Poster MicroScan Meropenem/vaborbactam MIC Results Correlate with ISO/CLSI Reference Panels

Download the ECCMID 2020 poster for complete information showing the accuracy of meropenem/vaborbactam MIC panel results for Enterobacterales and P. aeruginosa correlated with frozen ISO/CLSI broth microdilution reference panel. Analyze the multicenter study’s methods, quality control parameters and conclusions based on EUCAST interpretive criteria.

Download Poster

Related Posters

ECCMID 2020: Cephalexin MIC Results for Enterobacterales Using EUCAST Breakpoints on MicroScan Dried Gram Negative MIC Panels
PROMPT® is a registered trademark of 3M Company, St. Paul, MN USA.
Products
Support
Company Newsletter
Beckman Coulter Life Sciences
Stay Connected
Products
Support
Company
Newsletter
Beckman Coulter Life Sciences
Stay Connected

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

 

© 2024 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.